Pre-made Glenzocimab benchmark antibody ( Fab, anti-GP6 therapeutic antibody, Anti-BDPLT11/GPIV/GPVI Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-247
Awaiting product image

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-247 Category Tag

For more than 100mg, click here for inquiry. >>

inquire

Product Details

Pre-Made Glenzocimab biosimilar, Fab, Anti-GP6 Antibody: Anti-BDPLT11/GPIV/GPVI therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Glenzocimab biosimilar, Fab, Anti-GP6 Antibody: Anti-BDPLT11/GPIV/GPVI therapeutic antibody
INN Name

Glenzocimab
Target

GP6
Format

Fab
Derivation

Humanized
Species Reactivity

Human
CH1 Isotype

IgG1
VD LC

Kappa
Highest_Clin_Trial (Jan '20)

Phase-II
Est. Status

Active
100% SI Structure

None
99% SI Structure

None
95-98% SI Structure

None
Year Proposed

2018
Year Recommended

2019
Companies

Acticor Biotech
Conditions Approved

NA
Conditions Active

Stroke,COVID-19
Conditions Discontinued

NA
Development Tech

NA
Previous Name

NA
Gm Offical Target Name

GP6
Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide